EUVIMEDEUVIMED entdecken
Crossref

Case Studies

Chronicle of Diabetes Research and Practice · 2024

DOI: 10.4103/cdrp.cdrp_19_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chronicle of Diabetes Research and Practice, 2024.

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

HYPOTHYROIDISM WITH AUTOIMMUNE HYPOGLYCEMIA Awani Mukund Paithankar*, Uday Phadke *Sahyadri Super Speciality Hospital, Pune, Maharashtra, India E-mail: [email protected] A 69-year-old female, diagnosed with hypothyroidism 20 years ago, has consistently maintained stable thyroid-stimulating hormone levels with a daily dose of 75 μg of levothyroxine. She presented to the outpatient department reporting multiple episodes of altered sensorium regardless of meal time and inability to perceive her surroundings, which improved after eating. She was hospitalized once in an unconscious state and had symptomatic improvement after treatment with dextrose, but no blood sugar levels were recorded on the discharge card. She was advised to undergo a 72-h fasting test but deferred. On the same evening, she experienced a similar episode, prompting hospital admission, where her blood sugar level was 32 mg/dl, again treated with dextrose. The following day, she consented to the 72-h fasting protocol. Her hemogram, electrolytes, renal, and liver function tests were normal; she had no other comorbidities. She remained stable throughout the protocol. Her lowest recorded blood sugar was 68 mg/dl without hypoglycemic symptoms. After completing the fasting protocol, samples for plasma glucose, insulin, c-peptide, beta-hydroxybutyrate, and anti-insulin antibodies were collected. On consuming a meal (two plates of poha), she experienced profuse sweating, with a blood sugar level of 28 mg/dl after 1 h. Subsequent analysis revealed negative results for initial samples at the end of the fasting protocol but positive anti-insulin antibodies in samples taken after the meal during hypoglycemia. MANAGEMENT OF NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS IN A PATIENT WITH DOWN SYNDROME USING CONTINUOUS GLUCOSE MONITORING: A CASE REPORT Saurabh Vivek Padole*, Jitendra Ingole *Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India E-mail: [email protected] This case demonstrates the successful management of newly diagnosed type 1 diabetes mellitus (T1DM) in a patient with Down syndrome using continuous glucose monitoring (CGM). CGM played a crucial role in improving glycemic control, reducing hypoglycemic episodes, and enhancing the patient’s quality of life. The multidisciplinary approach involving dieticians and psychology was essential in overcoming the challenges posed by the patient’s cognitive impairment. Individualized care and close monitoring are paramount in managing T1DM in patients with Down syndrome to achieve optimal outcomes. Further research and experience are needed to better understand the long-term benefits and challenges of using CGM in this population. Nonetheless, this case highlights the potential of CGM as a valuable tool in the management of T1DM in patients with Down syndrome, emphasizing the importance of tailored approaches to care in improving overall health outcomes. Unraveling a Diagnostic Enigma – A Case Report on Recurrent Diabetic Ketoacidosis in a 47-Year-Old Woman Sakshi Chittimaneni*, Preeti Gholap *Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India E-mail: [email protected] The main objective of this case report is to present a diagnostic dilemma encountered in a 47-year-old lady from Satara with recurrent diabetic ketoacidosis (DKA), leading to the eventual diagnosis of latent autoimmune diabetes in adults (LADA). The primary aim is to describe the atypical manifestations of new-onset (suspected) type 2 diabetes which later turned out to be LADA, thus highlighting the need for prompt diagnosis and tailored therapeutic strategies. The case report involved a thorough examination of the patient’s medical history, clinical features, and laboratory investigations. Important investigations included blood gas analysis, blood sugar levels, urine routine, renal function tests, C-peptide levels, and serological markers for autoimmune diabetes. The patient was diagnosed with diabetes mellitus 6 months ago and presented with symptoms of nausea and abdominal pain suggestive of DKA. Laboratory findings confirmed the diagnosis of LADA, supported by hyperglycemia, ketosis, raised C-peptide levels, and positive autoimmune markers (anti-GAD 65 and anti-islet cell antibodies). Prompt insulin therapy, initially through insulin infusion and later with long- and short-acting insulin, provided effective treatment. This showed the diagnostic challenges in the early detection of LADA and its importance in improving outcomes. In India, where diabetes is widespread, many cases of LADA get misdiagnosed, delaying proper treatment and causing more damage to the insulin-producing β-cells. Recognizing LADA early is crucial as it aids in predicting accelerated disease progression, anticipating an earlier need for insulin therapy, monitoring and preventing subtherapeutic responses to oral hypoglycemic agents, and identifying a greater risk of ketoacidosis and its prevention. Our patient’s swift transition to insulin therapy at diagnosis highlights the importance of early diagnosis of LADA in achieving optimal glycemic control. Early diagnosis of LADA, therefore, helps establish expectations for the disease course and provides valuable insights for its management. UNRAVELING UNUSUAL ORBITAL CELLULITIS PATTERNS IN NEWLY IDENTIFIED TYPE 2 DIABETES MELLITUS PATIENTS: A CASE SERIES STUDY Pranav Shelke*, Jitendra Ingole *Smt Kashibai Navale Medical College, Pune, Maharashtra, India E-mail: [email protected] Orbital cellulitis, an uncommon condition characterized by inflammation and infection of the tissues surrounding the eye, typically presents with localized symptoms such as periorbital swelling, pain, and impaired eye movement. While it is primarily considered an ophthalmologic emergency, rare cases have illuminated its potential role as a clinical indicator of underlying systemic disorders. We present a remarkable case of orbital cellulitis unveiling the diagnosis of type 2 diabetes mellitus (T2DM) in a young male patient, demonstrating the intricate interplay between ophthalmologic manifestations and systemic disease processes. The patient initially sought medical attention for acute onset of periorbital swelling, pain, and erythema, consistent with a diagnosis of orbital cellulitis. Prompt evaluation, including imaging studies and laboratory investigations, confirmed the diagnosis. However, amidst the diagnostic workup, unexpectedly elevated blood glucose levels were detected, prompting further evaluation for diabetes mellitus. Subsequent comprehensive metabolic assessments corroborated the diagnosis of T2DM. This unexpected finding prompted a reevaluation of the patient’s clinical presentation, shedding light on the nuanced relationship between orbital cellulitis and underlying metabolic abnormalities. This case highlights the importance of maintaining a high index of suspicion for underlying systemic diseases, even in the setting of seemingly localized ophthalmologic conditions. The association between orbital cellulitis and T2DM, though rare, underscores the necessity of comprehensive evaluation and multidisciplinary management approaches in clinical practice. Furthermore, it emphasizes the pivotal role of ophthalmologists and primary care providers in recognizing and addressing atypical presentations of systemic disorders, thereby facilitating timely diagnosis and intervention. By elucidating this unique case, we aim to broaden the understanding of the potential clinical implications of orbital cellulitis and underscore the importance of a holistic approach to patient care, encompassing both ophthalmologic and systemic perspectives. DIABETES MELLITUS TYPE 2 WITH AUTOIMMUNE HYPOGLYCEMIA Awani Mukund Paithankar*, Uday Phadke *Sahyadri Super Speciality Hospital, Pune, Maharashtra, India E-mail: [email protected] A 56-year-old female diagnosed with type 2 diabetes mellitus was initiated on metformin 250 mg twice daily 2 years ago, as her HbA1c at the time was 6.9%. Recent HbA1c reads 7%. However, her fasting blood glucose levels range between 60 and 80 mg/dl, with postdinner glucose measuring 119. She has been experiencing multiple episodes of hypoglycemia, characterized by symptoms of sweating and palpitations regardless of mealtime. Consequently, her metformin dosage was gradually tapered and eventually ceased. Blood samples were obtained for plasma glucose, insulin, C-peptide, beta-hydroxybutyrate, and anti-insulin antibodies. The insulin level measured was 1000 μIU/dl, with elevated C-peptide, negative beta-hydroxybutyrate, and positive anti-insulin antibody. Treatment involved dietary modifications, resulting in a reduction of her HbA1c to 6.9%, with fasting blood glucose at 134 and postprandial glucose levels at 158. Symptomatically, she showed improvement. CONTINUOUS GLUCOSE MONITORING FOLLOWED BY DIAZOXIDE THERAPY FOR MANAGEMENT OF PERSISTENT POSTBARIATRIC HYPOGLYCEMIA: A CASE REPORT Sudeep Jain*, Ankur Sharma, Manish Bothale, R. Dharini, Ragini Bhake, Vedavati Purandare, A. G. Unnikrishnan *Chellaram Diabetes Institute, Pune, Maharashtra, India E-mail: [email protected] Postbariatric hypoglycemia is an underrecognized complication of sleeve gastrectomy, one of the commonly performed bariatric surgeries in people with morbid obesity (body mass index >40 kg/m²). The mechanism behind postbariatric hypoglycemia could be due to a hyperinsulinemic response caused by nutrient movement. A 56-year-old lady presented with neuroglycopenic symptoms for the last 2 months. She underwent sleeve gastrectomy 16 years ago, and postoperatively, she experienced successful weight loss initially, which persisted until 2 years ago. Continuous glucose monitoring confirmed hypoglycemia, and postbariatric hypoglycemia was documented. On evaluation, there was no evidence of insulinoma or other pancreatic pathology. She was treated with dietary modification of a complex carbohydrate diet with small, frequent meals, diazoxide, and voglibose, resulting in the improvement of neuroglycopenic symptoms as well as glucose levels. Postbariatric hypoglycemia or late dumping syndrome is a complication of sleeve gastrectomy. Although the specific mechanism is not clear, one possible mechanism is the rapid emptying of gastric contents with a high concentration of carbohydrates in the small intestine, causing a hyperinsulinemic response and resulting in hypoglycemia. Further research is needed for a better understanding of the mechanisms underlying postbariatric hypoglycemia and its treatment. Continuous glucose monitoring can be an excellent tool for diagnosis and management. ALPELISIB-INDUCED HYPERGLYCEMIA – A CASE REPORT Suhail M Shaikh*, Prashant Bhalekar, Ragini Bhake, Vedavati B. Purandare, A. G. Unnikrishnan *Chellaram Diabetes Institute, Pune, Maharashtra, India E-mail: [email protected] Alpelisib, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, is used to treat hormone receptor-positive, human epidermal growth receptor 2-negative, PIK3 catalytic alpha-mutated locally advanced or metastatic breast cancer. Hyperglycemia is the most common adverse effect associated with alpelisib treatment. The PI3K pathway plays a key role in regulating glucose metabolism. Hyperglycemia due to the inhibition of PI3K-alpha blocks the action of insulin, reduces glucose uptake from skeletal muscles and adipose tissue, and increases glycogenolysis. Approximately 60% of patients treated with alpelisib experience hyperglycemia, which can sometimes necessitate dose reductions, treatment interruptions, or even discontinuation of alpelisib. A 64-year-old female with metastatic breast cancer was started on alpelisib by her oncologist and referred to us for the management of her high glucose level. She had no history of diabetes, and her HbA1c was within the normal range, but her postprandial glucose levels were deranged. We regularly monitored her blood glucose levels by SMBG and advised lifestyle modification (dietary adjustments). On follow-up assessment after 2 weeks, the patient developed hyperglycemia which was subsequently managed with oral medications. Close monitoring of blood glucose levels is crucial for patients receiving alpelisib treatment, especially those with diabetes or prediabetes. Prompt and appropriate intervention is necessary for any worsening of blood glucose levels to optimize treatment outcomes. ROLE OF MINIMUM DOSE OF PIOGLITAZONE IN POSTCORONARY ARTERY BYPASS GRAFTING CASE: ANALYSIS OF 15-YEAR LONGITUDINAL DATA Sunil Kamble K. J. Somaiya Super Speciality Hospital, Sion, Maharashtra, India E-mail: [email protected] Pioglitazone should be avoided in heart failure/postmyocardial infarction (MI) cases due to the side effect of fluid retention. To examine the effect of pioglitazone on mortality and macrovascular morbidity in a patient with type 2 diabetes with MI, 15 years of longitudinal data of a postcoronary artery bypass grafting (CABG) case on a minimum dose of pioglitazone (7.5 mg) were analyzed. A 58-year-old male with no history of hypertension, diabetes mellitus, dyslipidemia, or any addiction was presented to the emergency room in 2008 with retrosternal burning pain, not relieved with antacids. Electrocardiogram revealed an inferior wall MI, hospitalized in the intensive care unit and thrombolysed with streptokinase. Subsequent investigations diagnosed him with hypertension, diabetes mellitus, and dyslipidemia. Coronary angiography showed triple-vessel disease with a left ventricular ejection fraction of 45%. He underwent CABG on November 11, 2008. Post-CABG, he was initiated on antihypertensive medication and statins as advised by cardiac surgeon and cardiologists. He was prescribed insulin, gliclazide (80 mg) + metformin (500 mg), and pioglitazone 15 mg initially, which were gradually changed to metformin (500 mg) 1-0-1/2 and pioglitazone (7.5 mg) over 3 months. The same treatment continued to date without any complaint. Data regarding weight, HbA1c, blood pressure, low-density lipoprotein cholesterol, two-dimensional echocardiography, fundus examination, Urine Albumin-Creatinine Ratio, hypoglycemic events, and hospitalizations were collected at admission, 3 months, 1 year, 5 years, 10 years, and 15 years and compiled to assess benefits or complications onset. HbA1c reduced from 9.8% to 6.9% with no new complication onset, hypoglycemia, or hospitalization in the last 15 years. Pioglitazone (7.5 mg) not only lowers HbA1c levels but also helps prevent hypoglycemic episodes, hospitalizations, and the development of both microvascular and macrovascular complications in the long term. TRIANGLE OF “SYMMETRICAL PERIPHERAL GANGRENE” – DIABETES, INFECTION, AND VASOPRESSOR J. Josephin Antoniammal Holy Cross Hospital, Kalyan, Maharashtra, India E-mail: [email protected] Symmetrical peripheral gangrene (SPG) is a rare disorder leading to ischemic necrosis of extremities. We present a rare case of idiopathic SPG in a 67-year-old male who was admitted to the intensive care unit for left upper limb necrotizing fasciitis, with septic shock and disseminated intravascular coagulation secondary to the necrotizing fasciitis. The blood pressure was 70/40 mmHg. On admission, hemogram showed a total count of 24,000, platelets 1.75 lakh, creatinine of 3.2 mg/dl, C-reactive protein 72mg/dl, procalcitonin >200 ng/mL, ABG showed, metabolic acidosis with a pH of 7.1 HCO3 10 mEq/L, CO2 19.9 M Eq/L and lactate 7.20 mmol/l. Random blood glucose was

Zitieren

APA

(2024). Case Studies. Chronicle of Diabetes Research and Practice. https://doi.org/10.4103/cdrp.cdrp_19_24

Vancouver

Case Studies. Chronicle of Diabetes Research and Practice. 2024. doi:10.4103/cdrp.cdrp_19_24

BibTeX
@article{euvimed2024,
  title = {Case Studies},
  journal = {Chronicle of Diabetes Research and Practice},
  year = {2024},
  doi = {10.4103/cdrp.cdrp_19_24}
}
Kostenlos starten →